AU2003248876A1 - MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE - Google Patents
MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USEInfo
- Publication number
- AU2003248876A1 AU2003248876A1 AU2003248876A AU2003248876A AU2003248876A1 AU 2003248876 A1 AU2003248876 A1 AU 2003248876A1 AU 2003248876 A AU2003248876 A AU 2003248876A AU 2003248876 A AU2003248876 A AU 2003248876A AU 2003248876 A1 AU2003248876 A1 AU 2003248876A1
- Authority
- AU
- Australia
- Prior art keywords
- mp53s
- modifiers
- pathway
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003607 modifier Substances 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/12—Applications; Uses in screening processes in functional genomics, i.e. for the determination of gene function
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39499202P | 2002-07-10 | 2002-07-10 | |
| US60/394,992 | 2002-07-10 | ||
| US40160402P | 2002-08-07 | 2002-08-07 | |
| US60/401,604 | 2002-08-07 | ||
| US41098802P | 2002-09-16 | 2002-09-16 | |
| US60/410,988 | 2002-09-16 | ||
| US42883702P | 2002-11-25 | 2002-11-25 | |
| US60/428,837 | 2002-11-25 | ||
| PCT/US2003/021378 WO2004004766A1 (en) | 2002-07-10 | 2003-07-09 | MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003248876A1 true AU2003248876A1 (en) | 2004-01-23 |
Family
ID=30119334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003248876A Abandoned AU2003248876A1 (en) | 2002-07-10 | 2003-07-09 | MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003248876A1 (en) |
| WO (1) | WO2004004766A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407062B1 (en) * | 1995-09-27 | 2002-06-18 | St. Jude Children's Research Hospital | ARF-P19, a novel regulator of the mammalian cell cycle |
| US7259278B2 (en) * | 2000-11-29 | 2007-08-21 | Cytoskeleton Inc. | Anti-S-phase tubulin ligands |
-
2003
- 2003-07-09 WO PCT/US2003/021378 patent/WO2004004766A1/en not_active Ceased
- 2003-07-09 AU AU2003248876A patent/AU2003248876A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004004766A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003216482A1 (en) | MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| AU2002310256A1 (en) | Ppp2cs as modifiers of the p53 pathway and methods of use | |
| AU2002324598A1 (en) | Trps as modifiers of the p53 pathway and methods of use | |
| AU2002314887A1 (en) | Gads as modifiers of the p53 pathway and methods of use | |
| AU2003248879A1 (en) | RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| AU2003272390A1 (en) | AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| AU2003295881A1 (en) | Lamps as modifiers of the p53 pathway and methods of use | |
| AU2003303094A1 (en) | MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| AU2003251799A1 (en) | Mchks as modifiers of the chk1 pathway and methods of use | |
| AU2003265263A1 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| AU2003274911A1 (en) | Mrbs as modifiers of the rb pathway and methods of use | |
| AU2003258095A1 (en) | MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
| AU2003251826A1 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
| AU2003248876A1 (en) | MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| AU2003278811A1 (en) | LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
| AU2003263993A1 (en) | MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE | |
| EP1578945A3 (en) | Cct6s as modifiers of the rb pathway and methods of use | |
| AU2003294499A1 (en) | Rhebs as modifiers of the rb pathway and methods of use | |
| AU2003299990A1 (en) | Mbcats as modifiers of the beta-catenin pathway and methods of use | |
| AU2003217851A1 (en) | MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE | |
| AU2002312283A1 (en) | Srpks as modifiers of the p53 pathway and methods of use | |
| AU2002303947A1 (en) | Pecis as modifiers of the p53 pathway and methods of use | |
| AU2002303951A1 (en) | Glras as modifiers of the p53 pathway and methods of use | |
| AU2002345486A1 (en) | Slc13as as modifiers of the p53 pathway and methods of use | |
| AU2002357817A1 (en) | Klcs as modifiers of the p53 pathway and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |